🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
This is a multicenter, open-label, Phase 1b/2 efficacy and safety study of ...
Status
Terminated
Location
Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii
Start Date
2022-12-07
Trial ID
NCT04915404
Treatments Being Tested
The overall goal of this exploratory proof-of-concept study is to determine...
Status
Completed
Location
Task Applied Science and Stellenbosch University
Start Date
2017-08-23
Trial ID
NCT03174184
This is a multicenter, randomized, double-blind, placebo-controlled, dose-E...
Status
Completed
Location
Allife Medicine （Beijing） Limitied
Start Date
2023-08-24
Trial ID
NCT05993884
This is an open-label, Phase II interventional study in order to assess eff...
Status
Completed
Location
University of Colorado Hospital
Start Date
2020-11-23
Trial ID
NCT04508647
Treatments Being Tested
Nutrition is an important modifiable risk factor of human cognitive health....
Status
Recruiting
Location
Palliative Care Centre "Panagia Glykofilousa", Greek Association of Alzheimer's Disease and Related Disorders, Plastira 65, Thessaloniki 54250, Greece.
Start Date
2025-03-31
Trial ID
NCT07672938
The purpose of this study is: * To assess the effect of BIA 5 1058 400 mg ...
Status
Completed
Location
Simbec Research Ltd (Simbec)
Start Date
2018-06-11
Trial ID
NCT07173738
Treatments Being Tested
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
The goal of this prospective study is to analyze volumetric changes in the ...
Status
Recruiting
Location
Penn Medicine
Start Date
2026-09-30
Trial ID
NCT07777926
Treatments Being Tested